In pivotal trials, EASI 75 and vIGA 0/1 responses were measured at Week 16, as early as Week 2. Reduced worst pruritus NRS ≥4 was measured at Week 16 with results observed 1 day after first dose for RINVOQ 30 mg or 2 days after first dose for RINVOQ 15 mg.